Alcohol withdrawal

Southern Medical Journal

Volumn 105, Issue 11, 2012, Pages 607-612

  Manasco, Anton ^a   Chang, Shannon ^a   Larriviere, Joseph ^a   Hamm, L Lee ^a   Glass, Marcia ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

alcohol withdrawal symptoms; alcohol withdrawal treatment; benzodiazepine; Clinical Institute Withdrawal Assessment for Alcohol; fixed schedule dosing; symptom triggered dosing

Indexed keywords

ABECARNIL; ALPRAZOLAM; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BACLOFEN; BARBITAL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOMETHIAZOLE; CLONIDINE; DIAZEPAM; HALOPERIDOL; HYDROXYZINE; LORAZEPAM; MAGNESIUM; MIDAZOLAM; NITROUS OXIDE; PHENOBARBITAL; PHENOTHIAZINE DERIVATIVE; PLACEBO; PROPRANOLOL; TETRABAMATE; THIAMINE; THIORIDAZINE; UNINDEXED DRUG; VALPROIC ACID;

ALCOHOL WITHDRAWAL; CLINICAL FEATURE; CLINICAL INSTITUTE WITHDRAWAL ASSESSMENT FOR ALCOHOL SCORING SYSTEM; CLINICAL PROTOCOL; CONTINUING EDUCATION; CONTINUOUS INFUSION; DELIRIUM TREMENS; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG EFFICACY; HEALTH CARE PERSONNEL; HEALTH CARE PERSONNEL MANAGEMENT; HEALTH CARE QUALITY; HUMAN; HYPOMAGNESEMIA; MEDICAL ASSESSMENT; META ANALYSIS (TOPIC); NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATION DEPRESSION; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WITHDRAWAL SEIZURE;

ALCOHOL WITHDRAWAL DELIRIUM; ALCOHOL WITHDRAWAL SEIZURES; ANTICONVULSANTS; BENZODIAZEPINES; CLINICAL PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; HEALTH STATUS INDICATORS; HUMANS; HYPNOTICS AND SEDATIVES; QUALITY IMPROVEMENT;

EID: 84869405612     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31826efb2d     Document Type: Review

References (21)

1. Phillips S, Haycock C, Boyle D. Development of an alcohol withdrawal protocol. Clin Nurse Spec 2006;20:190-198.
2. Riddle E, Bush J, Tittle M, et al. Alcohol withdrawal: development of a standing order set. Crit Care Nurse 2010;30:38-47.
3. National Institute on Alcohol Abuse and Alcoholism five year strategic plan, FY07-11, alcohol across the lifespan. http://pubs.niaaa.nih.gov/ publications/StrategicPlan/NIAAASTRATEGICPLAN.htm. Accessed May 13, 2012.
4. Dodd PR, Beckmann AM, Davidson MS, et al. Glutamate-mediated transmission, alcohol, and alcoholism. Neurochem Int 2000;37:509-533.
5. Hughes JR. Alcohol withdrawal seizures. Epilepsy Behav 2009;15:92-97.
6. Monte R, Rabunal R, Casariego E, et al. Risk factors for delirium tremens in patients with alcohol withdrawal syndrome in a hospital setting. Eur J Intern Med 2009;20:690-694.
7. Stern TA. Alcohol-induced disorders. In: Stern TA, Rosenbaum JF, Fava M, et al, eds. Massachusetts General Hospital Comprehensive Clinical Psychiatry. 1st ed. New York: Mosby/Elsevier; 2008:1059-1060.
8. Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 2011;7:284-294.
9. Mayo-Smith MF. Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. JAMA 1997; 278:144-151.
10. Amato L, Minozzi S, Vecchi S, et al. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev 2010;17:CD005064.
11. Weaver MF, Hoffman HK, Johnson RE, et al. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. J Addict Dis 2006;25:17-24.
12. DeCarolis DD, Rice KL, Ho L, et al. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy 2007;27:510-518.
13. Stanley KM, Worrall CI, Lunsford SI, et al. Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients. Pharmacotherapy 2005;25:1073-1083.
14. Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixedschedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Arch Intern Med 2002;162:1117-1121.
15. Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA 1994;272:519-523.
16. Hecksel KA, Bostwick JM, Jaeger TM, et al. Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clinic Proc 2008;83:274-279.
17. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IValcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007;64:830-842.
18. Hack J, Hoffman R, Nelson L. Resistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2006;2:55-60.
19. Gold JA, Rimal B, Nola A, et al. A strategy of escalating doses of benzodiazepines and phenobarbital administration reduces the need for mechanical ventilation in delirium tremens. Crit Care Med 2007;35:724-730.
20. Spies CD, Otter HE, Huske B, et al. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Intens Care Med 2003;29:2230-2238.
21. Elholm B, Larsen K, Hornnes N, et al. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting. Alcohol Alcohol 2011;46:318-323.